My NCBI | Sign In
RSS Settings
  • Search: Elbrønd B[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 3

    1.

    Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects.

    Elbrønd B, Jakobsen G, Larsen S, Agersø H, Jensen LB, Rolan P, Sturis J, Hatorp V, Zdravkovic M.

    Diabetes Care. 2002 Aug;25(8):1398-404.PMID: 12145241 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.

    Agersø H, Jensen LB, Elbrønd B, Rolan P, Zdravkovic M.

    Diabetologia. 2002 Feb;45(2):195-202.PMID: 11935150 [PubMed - indexed for MEDLINE]Related articles

    3.

    Complete histological regression of Kaposi's sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions.

    Benfield TL, Kirk O, Elbrønd B, Pedersen C.

    Scand J Infect Dis. 1998;30(6):613-5.PMID: 10225394 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity